戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ivated receptors, and nitric oxide releasing nonsteroidal antiinflammatory agents.
2 onverting-enzyme inhibitors (8 percent), and nonsteroidal antiinflammatory agents (8 percent).
3 ts with mucosal injury related to the use of nonsteroidal antiinflammatory agents and may be an impor
4 set JRA were continued on a daily regimen of nonsteroidal antiinflammatory agents and prednisone, wit
5  dosage recommendations; applications of the nonsteroidal antiinflammatory agents are also discussed.
6             Although Helicobacter pylori and nonsteroidal antiinflammatory agents have been identifie
7                       Nitric oxide releasing nonsteroidal antiinflammatory agents have potential usef
8 sk of colon cancer development and intake of nonsteroidal antiinflammatory agents, including aspirin.
9               One of the mechanisms by which nonsteroidal antiinflammatory agents inhibit colon carci
10                              HAART used with nonsteroidal antiinflammatory agents leads to the suppre
11                                              Nonsteroidal antiinflammatory agents (NSAIA) have been s
12                                         Many nonsteroidal antiinflammatory agents (NSAIDs) bind to pr
13  way of managing inflammatory pain is to use nonsteroidal antiinflammatory agents (NSAIDs) that reduc
14           In comparing aspirin, nonselective nonsteroidal antiinflammatory agents (NSAIDs), and cyclo
15 rheumatoid arthritis to date has depended on nonsteroidal antiinflammatory agents such as aspirin.
16 ism by which dietary omega-3 fatty acids and nonsteroidal antiinflammatory agents such as Celecoxib s
17 ) might retain all the benefits of classical nonsteroidal antiinflammatory agents while avoiding the
18 ng compounds having therapeutic potential as nonsteroidal antiinflammatory agents with an enhanced ga

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。